Tian Ran Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Tian Ran Zhu has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
David H. Ciocon
Department of Medicine, Division of Dermatology Albert Einstein College of Medicine/Montefiore Medical Center the Bronx NY USA
1 shared publicationK.A. Tran
Department of Medicine, University of Arizona, Tucson, AZ, U.S.A.
1 shared publication- Karolina Mieczkowska
Department of Medicine, Division of Dermatology Albert Einstein College of Medicine/Montefiore Medical Center the Bronx NY USA
1 shared publication Onjona Hossain
Department of Medicine, Division of Dermatology Albert Einstein College of Medicine/Montefiore Medical Center the Bronx NY USA
1 shared publicationR.K. Sivamani
Department of Dermatology, University of California, Davis, Sacramento, CA, U.S.A.
1 shared publicationRamone F. Williams
Department of Dermatology Massachusetts General Hospital Harvard Medical School Boston MA USA
1 shared publication
Latest Publications
- 15 May 2018
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 179 (3) , 570-581
Epithelial barrier dysfunctions in atopic dermatitis: a skin-gut-lung model linking microbiome alteration and immune dysregulation
Atopic dermatitis is a systemic disorder characterized by abnormal barrier function across multiple organ sites. Initial disruption in the skin epidermal barrier permits allergen sensitization and colonization by pathogens. This induces TH2 inflammatory response and a thymic stromal lymphopoietin mediated pathway that further promotes barrier breakdown at distant sites including the intestinal and respiratory tract. Clinically, atopic dermatitis can progress from skin disease to food allergy, allergic rhinitis, and later asthma, a phenomenon commonly known as the atopic march. Causes of epidermal barrier breakdown are complex and driven by a combination of structural, genetic, environmental, and immunologic factors. In addition, alteration in microflora diversity can influence disease severity, duration, and response to treatment. This review addresses how epithelial dysfunction linking microbiome alteration and immune dysregulation can predispose to development of the atopic march. Because there are no immediate cures for food allergy or asthma, early intervention aimed at protecting the skin barrier and effective control of local and systemic inflammation may improve long term outcomes and reduce allergen sensitization to the airway and gut.
- 15 May 2018
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 179 (3) , 570-581
Epithelial barrier dysfunctions in atopic dermatitis: a skin-gut-lung model linking microbiome alteration and immune dysregulation
Atopic dermatitis is a systemic disorder characterized by abnormal barrier function across multiple organ sites. Initial disruption in the skin epidermal barrier permits allergen sensitization and colonization by pathogens. This induces TH2 inflammatory response and a thymic stromal lymphopoietin mediated pathway that further promotes barrier breakdown at distant sites including the intestinal and respiratory tract. Clinically, atopic dermatitis can progress from skin disease to food allergy, allergic rhinitis, and later asthma, a phenomenon commonly known as the atopic march. Causes of epidermal barrier breakdown are complex and driven by a combination of structural, genetic, environmental, and immunologic factors. In addition, alteration in microflora diversity can influence disease severity, duration, and response to treatment. This review addresses how epithelial dysfunction linking microbiome alteration and immune dysregulation can predispose to development of the atopic march. Because there are no immediate cures for food allergy or asthma, early intervention aimed at protecting the skin barrier and effective control of local and systemic inflammation may improve long term outcomes and reduce allergen sensitization to the airway and gut.